Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronny Drapkin

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Investigation|February 9, 2021
Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancerHelen E Burston, Oliver A Kent, Laudine Communal, et al.
Elife|May 13, 2025
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancerArkajyoti Bhattacharya, Thijs S Stutvoet, Mirela Perla, et al.
Advanced Biology|March 10, 2026
Tumor-Infiltrating Nociceptor Neurons in Ovarian Cancer Treatment ResistanceAllison Jorgensen, Daniel W Vermeer, Euihye Jung, et al.
Cell & Bioscience|November 7, 2023
MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancerMatias A Bustos, Takamichi Yokoe, Yoshiaki Shoji, et al.
Plos One|February 21, 2012
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancerStefan Bentink, Benjamin Haibe-Kains, Thomas Risch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
Aneuploidy Landscape in Precursors of Ovarian CancerYeh Wang, Christopher Douville, Yen-Wei Chien, et al.
Cell|February 28, 2015
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapyJoan Montero, Kristopher A Sarosiek, Joseph D DeAngelo, et al.
Cell|March 14, 2007
Further evidence for BRCA1 communication with the inactive X chromosomeDaniel P Silver, Stoil D Dimitrov, Jean Feunteun, et al.
Obstetrics and Gynecology|November 7, 2024
Optimization of Timing for Risk-Reducing Salpingectomy and OophorectomyKathryn P Pennington, Stephanie L Pugh, Warner Huh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT InhibitionGeorge Au-Yeung, Franziska Lang, Walid J Azar, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Investigation|February 9, 2021
Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancerHelen E Burston, Oliver A Kent, Laudine Communal, et al.
Elife|May 13, 2025
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancerArkajyoti Bhattacharya, Thijs S Stutvoet, Mirela Perla, et al.
Advanced Biology|March 10, 2026
Tumor-Infiltrating Nociceptor Neurons in Ovarian Cancer Treatment ResistanceAllison Jorgensen, Daniel W Vermeer, Euihye Jung, et al.
Cell & Bioscience|November 7, 2023
MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancerMatias A Bustos, Takamichi Yokoe, Yoshiaki Shoji, et al.
Plos One|February 21, 2012
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancerStefan Bentink, Benjamin Haibe-Kains, Thomas Risch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
Aneuploidy Landscape in Precursors of Ovarian CancerYeh Wang, Christopher Douville, Yen-Wei Chien, et al.
Cell|February 28, 2015
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapyJoan Montero, Kristopher A Sarosiek, Joseph D DeAngelo, et al.
Cell|March 14, 2007
Further evidence for BRCA1 communication with the inactive X chromosomeDaniel P Silver, Stoil D Dimitrov, Jean Feunteun, et al.
Obstetrics and Gynecology|November 7, 2024
Optimization of Timing for Risk-Reducing Salpingectomy and OophorectomyKathryn P Pennington, Stephanie L Pugh, Warner Huh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT InhibitionGeorge Au-Yeung, Franziska Lang, Walid J Azar, et al.
Pageof 18